Express Pharma

Session Highlights: Panel Discussion on 'Forging the path for tomorrow's therapeutics: Opportunities & Challenges' at the #FDDConclave 2024 ~ Forging The Path For Tomorrow Therapeutics | 20th July 2024| Hyderabad + Birendra Kumar David, VP, Delivery Manager-Inhalation and Head- Process Engineering, Dr. Reddy's Laboratories (Moderator) + Dr Shubhadeep Sinha, Sr VP, Head - Clinical Development & Medical Affairs (CD&MA), Hetero Labs + Dr. Tausif Ahmed, VP & Head - Biopharmaceutics & Bioequivalence, Dr. Reddy's Laboratories + Dr. Vasanthakumar Ramu FRSC, VP, Head of R&D - Peptides & Complex APIs, Alembic Pharmaceuticals Limited + Iranna Bavalatti, VP & Head Technology Transfer, Maiva Pharma Private Limited (FDA Approved Sterile Injectables) [1] Leveraging learnings from preclinical studies such as virtual bioequivalence through AI-driven solutions can streamline regulatory processes in clinical stages, ensuring data integrity and cutting down on approval times. [2] Clear roles and responsibilities and precise communication will help bridge the gap between R&D, manufacturing and supply chain, and aid the process of tech transfer, making it effective and faster. [3] Peptides drug development has seen significant progress. However, it is highly technical, and time-consuming, involving multiple challenges including extensive testing and impurity management. Hence, automating is the need of the hour.   [4] QbD, novel delivery strategies, emerging technologies like AI are aiding advancements in peptides drug development. For example, predicting immunogenecity risk with insilico tools, identifying nitrosamine impurities in peptides drug development etc [5] Patient needs will drive therapies of the future. It will involve patient-centric approaches to clinical trials, use of technology such as AI and automation to improve convenience for patients and boost health outcomes. CILICANT | MANISH JAIN | Fahmim Hussain | SUMEET SHARMA | Viveka Roychowdhury | Lakshmipriya Nair | Neha Aathavale | Kavita Jani | Rajesh Bhatkal | Ashish Rampure | Kalyani Sharma | douglas M. | Muhurta Shinde | Amruta Shinde | John P K | Vikram Vora

Session Highlights: Panel Discussion on 'Tech revolution in FR&D' at the #FDDConclave 2024 ~ Forging The Path For Tomorrow Therapeutics | 20th July 2024| Hyderabad + Dr Pirthi Pal Singh, PhD, PGDM, VP & Head - R&D, Tirupati Group (Moderator) + Dr. Madhusudhan Bommagani, President - R&D Formulation, Cadila Pharmaceuticals Limited + Amarender Reddy Donthidi, VP & Head - R&D Injectables and Ophthalmics, Amneal Pharmaceuticals + Sachin Arora, VP & Delivery Manager-Formulation Development-Oral Solids - US, EU, CA & Global Markets, Dr. Reddy's Laboratories + Dr Balasubramaniam Jagadish, VP- Formulation Development (PDU), Recipharm Pharmaservices + Dr. Pavan Bhat, MBA, Director and Executive VP (Technical Operations), NATCO Pharma [1] Pharma R&D generates a lot of useful data. Deploying data analytics and predictive tools can help identify overlooked patterns to gain crucial insights and drive meaningful outcomes [2] AI is crucial in pharma, from drug discovery to data science and machine learning. Data sciences integrate AI into systems to gain meaningful information. AI helps optimise processes, minimise manual errors, improve quality control, and ensure better product delivery [3] Drug excipient database developed with AI can aid FR&D scientists to increase the pace of drug development. [4] The pharma industry has made significant strides in technology adoption over the past five-six years. Major companies like Lupin, Cipla, and Reddy’s are investing heavily in AI for innovation, improved efficiency decision-making and enhanced product quality. [5] The generic industry can adopt AI through collaboration and data sharing, using predictive tools to analyse data and solve R&D and manufacturing issues. [6] AI rationalises formulation processes but faces challenges in customer experience and process efficiency. Scientists can leverage AI tools, data analytics and machine learning to gain pivotal benefits without replacing human expertise CILICANT | MANISH JAIN | Fahmim Hussain | SUMEET SHARMA | Viveka Roychowdhury | Lakshmipriya Nair | Neha Aathavale | Kavita Jani | Rajesh Bhatkal | Ashish Rampure | Kalyani Sharma | douglas M. | Muhurta Shinde | Amruta Shinde | John P K | Vikram Vora

#DigitalIssue of #ExpressPharma July 2024 ~ The Next Frontier: Global Leadership In BioPharma is out and available online at https://bit.ly/3XWWvyO Grab your FREE copy of #DigitalMagazine now! For Advertising & Digital Tie-Ups on Express Pharma, Please contact - Rajesh Bhatkal at rajesh.bhatkal@expressindia.com

#EventToday | Day 2 for #FDDConclave 2024 ~ Forging The Path For Tomorrow Therapeutics to begin shortly at Le Meridien Hyderabad | Presented by CILICANT Stay tuned on our social platforms for event updates MANISH JAIN | Fahmim Hussain | SUMEET SHARMA | Viveka Roychowdhury | Lakshmipriya Nair | Neha Aathavale | Kavita Jani | Rajesh Bhatkal | Ashish Rampure | Kalyani Sharma | douglas M. | Muhurta Shinde | Amruta Shinde | John P K | Vikram Vora

Key Takeaway: ‘India has proven its global capabilities beyond generics. New focus areas include biosimilars, biological entities, and complex generics’: Mr Raja Bhanu, Director General, Pharmexcil (Pharmaceuticals Export Promotion Council of India) at the #FDDConclave 2024 | 19th July 2024 | Hyderabad CILICANT | MANISH JAIN | Fahmim Hussain | SUMEET SHARMA | Viveka Roychowdhury | Lakshmipriya Nair | Neha Aathavale | Kavita Jani | Rajesh Bhatkal | Ashish Rampure | Kalyani Sharma | douglas M. | Muhurta Shinde | Amruta Shinde | John P K | Vikram Vora

Session Highlights: Address by Chief Guest - Mr Raja Bhanu, Director General, Pharmexcil (Pharmaceuticals Export Promotion Council of India) at the #FDDConclave 2024 ~ Forging The Path For Tomorrow Therapeutics | 19th July 2024 | Hyderabad [1] India has proved its mettle as the "Pharmacy of the World." Government budget allocations have encouraged growth in the sector [2] Quality and affordability of drugs are India's USPs. [3] Exports increased from USD 17.3 billion (2017-18) to USD 27.85 billion (2023-24) with a CAGR of 8.25%. Exports are projected to reach USD 55 billion by 2030. [4] India has proven its global capabilities beyond generics. New focus areas include biosimilars, biological entities, and complex generics. [5] Now, there is significant competition from neighboring countries. We need to optimise our strengths and mitigate our limitations with new technologies CILICANT | MANISH JAIN | Fahmim Hussain | SUMEET SHARMA | Viveka Roychowdhury | Lakshmipriya Nair | Neha Aathavale | Kavita Jani | Rajesh Bhatkal | Ashish Rampure | Kalyani Sharma | douglas M. | Muhurta Shinde | Amruta Shinde | John P K | Vikram Vora

#FDDConclave | Heartiest Congratulations to all the Award Winners at the #FDDLeadershipAwards 2024 | 19th July 2024 | Hyderabad | Organised by #ExpressPharma CILICANT | MANISH JAIN | Fahmim Hussain | SUMEET SHARMA | Viveka Roychowdhury | Lakshmipriya Nair | Neha Aathavale | Kavita Jani | Rajesh Bhatkal | Ashish Rampure | Kalyani Sharma | douglas M. | Muhurta Shinde | Amruta Shinde | John P K | Vikram Vora

#FDDConclave | Heartiest Congratulations to Mr Satish Chandra Upadhyay for winning in the 'Stalwarts' Category at the #FDDLeadershipAwards 2024 | 19th July 2024 | Hyderabad | Organised by #ExpressPharma CILICANT | MANISH JAIN | Fahmim Hussain | SUMEET SHARMA | Viveka Roychowdhury | Lakshmipriya Nair | Neha Aathavale | Kavita Jani | Rajesh Bhatkal | Ashish Rampure | Kalyani Sharma | douglas M. | Muhurta Shinde | Amruta Shinde | John P K | Vikram Vora

#FDDConclave | Heartiest Congratulations to Dr Saurabh Gupta for winning in the 'Leaders' Category at the #FDDLeadershipAwards 2024 | 19th July 2024 | Hyderabad | Organised by #ExpressPharma CILICANT | MANISH JAIN | Fahmim Hussain | SUMEET SHARMA | Viveka Roychowdhury | Lakshmipriya Nair | Neha Aathavale | Kavita Jani | Rajesh Bhatkal | Ashish Rampure | Kalyani Sharma | douglas M. | Muhurta Shinde | Amruta Shinde | John P K | Vikram Vora

#FDDConclave | Heartiest Congratulations to Dr Satish Patil for winning in the 'Leaders' Category at the #FDDLeadershipAwards 2024 | 19th July 2024 | Hyderabad | Organised by #ExpressPharma CILICANT | MANISH JAIN | Fahmim Hussain | SUMEET SHARMA | Viveka Roychowdhury | Lakshmipriya Nair | Neha Aathavale | Kavita Jani | Rajesh Bhatkal | Ashish Rampure | Kalyani Sharma | douglas M. | Muhurta Shinde | Amruta Shinde | John P K | Vikram Vora